Developing drugs for pediatricrare diseases. The company focuses on discovering the genetic basis for diseases and develops drugs that can intervene in the affected pathways.
Contact Information
Investors 2
| Date | Name | Website |
| 27.07.2022 | Ben Frankl... | sep.benfra... |
| - | Medical Ex... | medexcelca... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 16.04.2024 | Nobias Therapeutics Joins NVIDIA Inception Program for Start... | Nobias Therapeutics Nobias Therapeutics, a biotechnology company pioneering artificial intelligence ... | prweb.com/... |
| 19.04.2022 | Ben Franklin Approved $3.1M in 14 Early Stage Companies | sep.benfra... |